Filing Details
- Accession Number:
- 0001144204-14-022203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-11 17:12:40
- Reporting Period:
- 2014-04-09
- Filing Date:
- 2014-04-11
- Accepted Time:
- 2014-04-11 17:12:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509422 | R Allen Ritter | 3000 Kent Ave Ste A1-100 West Lafayette IN 47906 | Vp Of Manufacturing/Cmc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-04-09 | 1,000 | $21.16 | 11,722 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-04-10 | 12,560 | $2.10 | 24,282 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-04-10 | 10,000 | $3.06 | 34,282 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-04-10 | 12,560 | $0.00 | 12,560 | $2.10 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-04-10 | 10,000 | $0.00 | 10,000 | $3.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-02-01 | No | 4 | M | Direct | |
13,560 | 2018-02-12 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- This option is fully vested and immediately exercisable.